plivatinib 400 mg/1 tableta film tableta
pliva d.o.o.sarajevo - imatinib - film tableta - 400 mg/1 tableta - 1 filmom obložena tableta sadrži: 400 mg imatiniba
metotreksat zentiva 100 mg/ml otopina za injekciju/infuziju
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - metotreksat - otopina za injekciju / infuziju - 100 mg/ml - urbroj: jedna bočica s 10 ml otopine sadrži 1000 mg metotreksata (100 mg/ml)
metotreksat zentiva 2,5 mg/ml otopina za injekciju/infuziju
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - metotreksat - otopina za injekciju / infuziju - 2,5 mg/ml - urbroj: jedna bočica s 2 ml otopine sadrži 5 mg metotreksata (2,5 mg/ml)
metotreksat zentiva 25 mg/ml otopina za injekciju/infuziju
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - metotreksat - otopina za injekciju / infuziju - 25 mg/ml - urbroj: jedna bočica s 2 ml otopine sadrži 50 mg metotreksata (25 mg/ml)
imatinib actavis
actavis group ptc ehf - imatinib - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma - protein kinase inhibitors, antineoplastic agents - imatinib actavis is indicated for the treatment of: , paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment;, paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis;, adult patients with ph+ cml in blast crisis;, adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy;, adult patients with relapsed or refractory ph+ all as monotherapy;, adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements;, adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfr rearrangement;, the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. učinak иматиниба na ishod transplantacije koštane srži nije određena. imatinib actavis is indicated for: , in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic dfsp. iskustvo s иматинибом u bolesnika s mds/rafinerija u svezi s pdgfr генных permutacija-vrlo ograničen. nema kontroliranih istraživanja pokazuju kliničku korist ili povećanje preživljavanja za te bolesti.
imatinib sandoz 100 mg filmom obložene tablete
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - imatinibmesilat - filmom obložena tableta - 100 mg - urbroj: svaka filmom obložena tableta sadrži 100 mg imatiniba (u obliku mesilata)
imatinib sandoz 400 mg filmom obložene tablete
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - imatinibmesilat - filmom obložena tableta - 400 mg - urbroj: svaka filmom obložena tableta sadrži 400 mg imatiniba (u obliku mesilata)
plivatinib 100 mg filmom obložene tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - imatinibmesilat - filmom obložena tableta - 100 mg - urbroj: svaka filmom obložena tableta od 100 mg sadrži 100 mg imatiniba (u obliku imatinibmesilata)
plivatinib 400 mg filmom obložene tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - imatinibmesilat - filmom obložena tableta - 400 mg - urbroj: svaka filmom obložena tableta od 400 mg sadrži 400 mg imatiniba (u obliku imatinibmesilata)
vincristine pfizer 1 mg/ml otopina za injekciju
pfizer croatia d.o.o., slavonska avenija 6, zagreb, hrvatska - vinkristinsulfat - otopina za injekciju - 1 mg/ml - urbroj: jedna bočica sadrži 1 mg vinkristinsulfata